medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2019, Número 6

<< Anterior Siguiente >>

Rev Mex Urol 2019; 79 (6)


Development and validation of the Ureteral Stent Discomfort Test (USDT). A simple, effective, and easy-to-use tool for evaluating ureteral stent discomfort

Michel-Ramírez JM, Lujano-Pedraza H, Gaona-Valle LS, Muñoz-Lumbreras EG, Valdéz-Colín JA, Gaytán-Murguía M, Manríquez-Buelna RE, Quezada-León CS, Arias-Patiño JJG

Idioma: Ingles.
Referencias bibliográficas: 10
Paginas: 1-6
Archivo PDF: 238.87 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Regan SM, Sethi AS, Powelson JA, Goggins WC, Milgrom ML, Sundaram CP. Symptoms related to ureteral stents in renal transplants compared with stents placed for other indications. J Endourol. 2009;23(12):2047¨C50. doi: 10.1089/ end.2009.0112

  2. Miyaoka R, Monga M. Ureteral stent discomfort: Etiology and management. Indian J Urol. 2009;25(4):455¨C60. doi: 10.4103/0970- 1591.57910

  3. Chew BH, Knudsen BE, Nott L, Pautler SE, Razvi H, Amann J, et al. Pilot study of ureteral movement in stented patients: first step in understanding dynamic ureteral anatomy to improve stent comfort. J Endourol. 2007;21(9):1069¨C75. doi: 10.1089/ end.2006.0252

  4. Al-Kandari AM, Al-Shaiji TF, Shaaban H, Ibrahim HM, Elshebiny YH, Shokeir AA. Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J Endourol. 2007;21(7):698¨C702. doi: 10.1089/end.2007.9949

  5. Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX, Timoney AG. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003;169(3):1060¨C4. doi: 10.1097/01.ju.0000049198.53424.1d

  6. Leibovici D, Cooper A, Lindner A, Ostrowsky R, Kleinmann J, Velikanov S, et al. Ureteral stents: morbidity and impact on quality of life. Isr Med Assoc J. 2005;7(8):491¨C4.

  7. Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P. Is there a role for ¦Á-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol. 2011 Sep;186(3):928¨C 34. doi: 10.1016/j.juro.2011.04.061

  8. T¨¹rk C, Neisius A, Petrik A, Seitz C, Skolarikos A, Thomas K. EAU Guidelines of Urolithiasis. European Association of Urology; 2018.

  9. Park SC, Jung SW, Lee JW, Rim JS. The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms. J Endourol. 2009;23(11):1913¨C7. doi: 10.1089/end.2009.0173

  10. Stant LT, Aaen PH, Ridler NM. Comparing methods for evaluating measurement uncertainty given in the JCGM ¡®Evaluation of Measurement Data¡¯ documents. Measurement. 2016; 94:847¨C51. doi: 10.1016/j.measurement.2016.08.015




2020     |     www.medigraphic.com